Company Overview of Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc., develops and commercializes drugs to treat metastatic cancer. The company focuses on developing CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Its products are used for the treatment of cancer and inflammatory diseases. The company was formerly known as Metastatix, Inc. Altiris Therapeutics, Inc. was founded in 2005 and is based in Atlanta, Georgia.
311 Ferst Drive, NW
Atlanta, GA 30332
Founded in 2005
Key Executives for Altiris Therapeutics, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Altiris Therapeutics, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.